Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Arturo Sanchez

Physician Assistant Phoenix, AZ Physician Assistant

NPI 1891314761 CMS profile 11254075

4220 W Bethany Home Rd, Phoenix, AZ 85019

Open in the dashboard

General payments

$15,559

913 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Arturo Sanchez of Phoenix, AZ is reported in the CMS Open Payments database as having received $15,559 across 913 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,251 18
2024 General $3,679 244
2023 General $4,229 279
2022 General $3,739 198
2021 General $2,661 174

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arturo Sanchez
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Arturo Sanchez were reported at $1,251. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Arturo Sanchez Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,661 $132 $37–$438 $132
2022 $3,739 $155 $48–$522 $149
2023 $4,229 $167 $52–$557 $160
2024 $3,679 $178 $55–$600 $164
2025 $1,251 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $1,593 26 payments
  2. AbbVie, Inc. $1,503 102 payments
  3. UCB, Inc. $1,402 108 payments
  4. Abbott Laboratories $1,171 46 payments
  5. SK Life Science, Inc. $885 47 payments
  6. Amneal Pharmaceuticals LLC $807 74 payments
  7. Teva Pharmaceuticals USA, Inc. $791 47 payments
  8. Genentech USA, Inc. $718 35 payments
  9. Argenx US, Inc. $625 40 payments
  10. Novartis Pharmaceuticals Corporation $538 34 payments
  11. Other $5,525 354 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $14,401 901 payments
  2. Travel and Lodging $819 4 payments
  3. Education $299 6 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $40 2 payments
Products named General payments · program years 2021–2025
  1. PERCEPT PC BRAINSENSE $1,142 12 payments
  2. Briviact $847 79 payments
  3. UBRELVY $705 52 payments
  4. INFINITY $703 6 payments
  5. RYTARY $658 62 payments
  6. QULIPTA $588 39 payments
  7. OCREVUS $553 28 payments
  8. KESIMPTA $538 34 payments
  9. NURTEC ODT $477 26 payments
  10. SenSight $451 14 payments
  11. Other $9,107 607 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 89 drugs

Part D claims

6,001

Median for Physician Assistant: 241

Drug cost

$4,081,730

Median for Physician Assistant: $4,110

Branded share of claims

27%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gammaked Immune Globul G/Gly/Iga Avg 46 Brand 130 $1,406,407
Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 Brand 53 $546,466
Octagam Immun Globg(Igg)/Malt/Iga Ov50 Brand 27 $315,830
Privigen Immun Glob G(Igg)/Pro/Iga 0-50 Brand 35 $208,723
Gamunex-C Immune Globul G/Gly/Iga Avg 46 Brand 28 $206,525
Rexulti Brexpiprazole Brand 99 $203,164
Nuplazid Pimavanserin Tartrate Brand 35 $170,847
Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 Brand 17 $149,327
Betaseron Interferon Beta-1b Brand 12 $120,077
Ingrezza Valbenazine Tosylate Brand 12 $115,632

The 10 drugs with the highest cost, of 89 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 36 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
$270 18 —
VYVGART Hytrulo
$247 — —
KESIMPTA
$227 — —
OCREVUS
$179 — —
VUMERITY
$178 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 36 with Patron

Records

913 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record